QuickMD has strict referencing policies and relies on reputable sources, including peer-reviewed research, clinical guidelines, medical organizations, and government and public health agencies, among others
If you stop GLP-1 medications completely, your sugar levels, appetite, and weight may return to pre-treatment levels
High-calorie foods, liquid calories, or frequent snacking can slow progress or lead to weight gain
Insurance authorization requirements, prior authorization denials, and coverage limitations create barriers to initiation and continuation
These findings may be relevant for health care professionals initiating tirzepatide in patients with T2D using antihypertensive medications, as this could be a potential opportunity to adjust antihypertensive medications if target blood pressure is reached